Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 1792-1808

  Pode Shakked, Naomi ^a,c   Metsuyanim, Sally ^a   Rom Gross, Eithan ^b   Mor, Yoram ^a,c   Fridman, Eduard ^a,c   Goldstein, Itamar ^a   Amariglio, Ninette ^a,c   Rechavi, Gideon ^a,c   Keshet, Gilmor ^a   Dekel, Benjamin ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Renal cancer; Renal development; Stem cell markers; Stem progenitor cells; Wilms' tumour

Indexed keywords

ANTINEOPLASTIC AGENT; NERVE CELL ADHESION MOLECULE; TUMOR MARKER;

ARTICLE; CANCER STEM CELL; CHILD; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY TUMOR; MALE; METABOLISM; NEPHROBLASTOMA; PATHOLOGY; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASTIC STEM CELLS; NEURAL CELL ADHESION MOLECULES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 72949107385     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00607.x     Document Type: Article

References (61)

1. Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer. 2005 5 : 699 712.
2. Feinberg AP, Williams BR. Wilms' tumor as a model for cancer biology. Methods Mol Biol. 2003 222 : 239 248.
3. Dekel B, Metsuyanim S, Schmidt-Ott KM, et al. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Res. 2006 66 : 6040 6049.
4. Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol. 2002 160 : 2181 2190.
5. Natrajan R, Reis-Filho JS, Little SE, et al. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse. Cancer Res. 2006 66 : 11148 11155.
6. Robison LL. The Childhood Cancer Survivor Study: a resource for research of long-term outcomes among adult survivors of childhood cancer. Minn Med. 2005 88 : 45 9.
7. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007 297 : 2705 2715.
8. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003 63 : 5821 5828.
9. van der Kooy D, Weiss S. Why stem cells Science. 2000 287 : 1439 1441.
10. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006 66 : 9339 9344.
11. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001 414 : 105 111.
12. Galmozzi E, Facchetti F, La Porta CA. Cancer stem cells and therapeutic perspectives. Curr Med Chem. 2006 13 : 603 607.
13. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006 444 : 756 760.
14. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997 3 : 730 737.
15. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004 432 : 396 401.
16. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005 65 : 5506 5511.
17. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007 445 : 106 110.
18. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005 65 : 10946 10951.
19. Metsuyanim S, Pode-Shakked N, Keshet GI, et al. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal-progenitor genes. Stem Cells. 2008 26 : 1808 1817.
20. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005 434 : 843 850. (Pubitemid 40558990)
21. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006 6 : 846 856.
22. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003 100 : 3983 3988. (Pubitemid 36418143)
23. Kirstetter P, Anderson K, Porse BT, et al. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol. 2006 7 : 1048 1056.
24. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2007 15 : 109 116.
25. Delorme B, Charbord P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med. 2007 140 : 67 81.
26. Song L, Webb NE, Song Y, et al. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells. 2006 24 : 1707 1718.
27. Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol. 2006 17 : 2443 2456.
28. Lou H, Dean M. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene. 2007 26 : 1357 1360.
29. Assou S, Le Carrour T, Tondeur S, et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells. 2007 25 : 961 973.
30. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999 5 : 1410 1412.
31. Dekel B, Zangi L, Shezen E, et al. Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol. 2006 17 : 3300 3314.
32. Tropepe V, Sibilia M, Ciruna BG, et al. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol. 1999 208 : 166 188.
33. Dekel B, Metsuyanim S, Garcia AM, et al. Organ-injury-induced reactivation of hemangioblastic precursor cells. Leukemia. 2008 22 : 103 113.
34. Lee TI, Jenner RG, Boyer LA, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006 125 : 301 313.
35. Yu J, Yu J, Rhodes DR, et al. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res. 2007 67 : 10657 10663.
36. Cui H, Ma J, Ding J, et al. Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration- dependent manner. J Biol Chem. 2006 281 : 34696 34704.
37. Marx J. Cancer research. Mutant stem cells may seed cancer. Science. 2003 301 : 1308 1310.
38. Babaie Y, Herwig R, Greber B, et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells. 2007 25 : 500 510.
39. Sakurai H, Barros EJ, Tsukamoto T, et al. An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors. Proc Natl Acad Sci USA. 1997 94 : 6279 6284.
40. Wittmann S WC, Zirn B, Furtwöngler R, et al. New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer. 2008 47 : 386 395.
41. Takahashi M, Yang XJ, Lavery TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res. 2002 62 : 6598 6605.
42. Tretiakova M, Turkyilmaz M, Grushko T, et al. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression. J. Clin. Pathol. 2006 59 : 1272 1277.
43. Ghanem MA, van Steenbrugge GJ, Nijman RJ, et al. Prognostic markers in nephroblastoma (Wilms' tumor). Urology. 2005 65 : 1047 1054.
44. Zirn B HO, Samans B, Krause M, et al. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer. 2006 118 : 1954 1962.
45. Tucci S Jr. CA, Suaid HJ, Valera ET, et al. Results of novel strategies for treatment of Wilms' tumor. Int Braz J Urol. 2007 33 : 195 201.
46. Marina NMW, J A : Meyer, W H : Jones, et al. Refining therapeutic strategies for patients with resistant Wilm's tumor. Am J Pediatr Hematol Oncol. 1994 16 : 296 300.
47. Boland GM, Perkins G, Hall DJ, et al. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J. Cell. Biochem. 2004 93 : 1210 1230.
48. Merkel CE, Karner CM, Carroll TJ. Molecular regulation of kidney development: is the answer blowing in the Wnt Pediatric Nephrol. 2007 22 : 1825 1838.
49. Schmidt-Ott KM, Yang J, Chen X, et al. Novel regulators of kidney development from the tips of the ureteric bud. J Am Soc Nephrol. 2005 16 : 1993 2002.
50. Koesters R RR, Kopp-Schneider A, Betts D, et al. Mutational activation of the fl-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res. 1999 59 : 3880 3882.
51. Bruno S, Bussolati B, Grange C, et al. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol. 2006 169 : 2223 2235.
52. Roth J, Zuber C, Wagner P, et al. Presence of the long chain form of polysialic acid of the neural cell adhesion molecule in Wilms' tumor. Identification of a cell adhesion molecule as an oncodevelopmental antigen and implications for tumor histogenesis. Am J Pathol. 1988 133 : 227 240.
53. Re GG, Hazen-Martin DJ, Sens DA, et al. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development. Semin Diagn Pathol. 1994 11 : 126 135.
54. Wilson PD. In vitro methods in renal research. In : Barratt TM, Avner ED, Harman WE, editor. Pediatric nephrology 4th ed. Baltimor, Maryland : Lippincott, Williams & Wilkins, 1999. pp. 320 360.
55. Daniel L, Bouvier C, Chetaille B, et al. Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior. Hum Pathol. 2003 34 : 528 532.
56. Michalides R, Kwa B, Springall D, et al. NCAM and lung cancer. Int J Cancer Suppl. 1994 8 : 34 7.
57. Wen JG, van Steenbrugge GJ, Egeler RM, et al. Progress of fundamental research in Wilms' tumor. Urol Res. 1997 25 : 223 230.
58. van Leeuwen EH, Postma A, Oosterhuis JW, et al. An analysis of histology and DNA-ploidy in primary wilms tumors and their metastases and a study of the morphological effects of therapy. Virchows Arch A Pathol Anat Histopathol. 1987 410 : 487 494.
59. Kudoh S NS, Nakano T, Komuta K, et al. Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: a phase II trial of West Japan Thoracic Oncology Group. Lung Cancer. 2005 49 : 263 269.
60. Pectasides D SE, Fountzilas G, Briasoulis E, et al. Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group. Lung Cancer. 2007 58 : 355 361.
61. Jensen M, Berthold F. Targeting the neural cell adhesion molecule in cancer. Cancer Lett. 2007 258 : 9 21.